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ABSTRACT
Purpose: To retrospectively evaluate angiographic and clinical outcomes of 
percutaneous  revascularization  in  diabetic  patients  with  Fontaine  stage  IV 
critical limb ischemia (CLI).
Materials and Methods: Clinical and procedural data were retrospectively 
collected of consecutive diabetic patients with Fontaine stage IV CLI who 
underwent  percutaneous limb revascularization from January 2009 to June 
2011.  Pre-  and  post-procedural  angiographic  images  were  retrospectively 
reviewed to classify lower limb arterial involvement according to 3 systems: 
1)  TASC  II;  2)  Graziani’s  morphological  classification;  3)  Joint  Vascular 
Society Council calf and foot scores. Foot lesions were graded according to 
the Texas University (TU) classification. Clinical results (healing, stability or 
major amputation) were compared to baseline clinical data and angiographic 
results. 
Results: In the study period, 202 percutaneous procedures were performed, 
with an immediate technical success rate of 93.6%. The majority of ulcers 
(75.7%) were deep (TU grades 2 and 3). Mean preprocedural calf and foot 
scores were 7.8±1.6 and 7.3±2.3, respectively; 132 patients (65.3%) were in 
Graziani’s morphological classes from 4 to 7 (at least two arteries occluded); 
in  112  (55.4%)  cases  TASC  II  was  inapplicable  (only  infrapopliteal 
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involvement). After the procedure, mean calf and foot scores were 4.8±2.3 
and 5.9±2.6, respectively, and 86.6% of cases were into the Graziani’s classes 
1 and 2, whereas TASC II was inapplicable in all  cases.  Healing rate was 
66.8%  and  major  amputation  rate  was  3.9%.  Among  all  the  clinical  and 
angiographic variables included in the analysis, only pre- and post-procedural 
foot scores were significantly associated to the clinical outcome (p=0.04).
Conclusion: TASC II is inadequate to describe vascular involvement in the 
vast majority of diabetic patients with CLI. In this population, percutaneous 
revascularization should represent the first-line treatment option, leading to 
high  healing  and  limb salvage  rates.  Pre-  and  post-procedural  foot  scores 
significantly  affect  chances  of  healing,  thus  aggressive  treatment  of  foot 
arteries should be attempted whenever possible. 
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INTRODUCTION
Lower limb peripheral arterial disease (PAD) is a common complication of 
diabetes mellitus and is associated with more severe clinical manifestations 
and a higher risk of critical limb ischemia (CLI) and limb loss in diabetic 
patients. Many recent studies have demonstrated the benefit derived from the 
percutaneous revascularization procedures on diabetic patients with CLI, in 
terms  of  high  rate  of  technical  success  and  limb  salvage,  facing  low 
periprocedural complication rates [1-7].
However, it’s still very difficult to compare the clinical results of the different 
trials, even the ones regarding only a diabetic population, in the absence of 
uniform criteria which describe the involvement of  the peripheral vascular 
system [8]. It is already known that the international guidelines, produced by 
the Intersociety Consensus for the Management of Peripheral Arterial Disease 
(TASC  II)  [9],  don’t  provide  any  description  of  PAD  in  patients  with  a 
infrapopliteal   arteries  damage,  and,  therefore,  they  are  not  useful  in  the 
diabetic population. An interesting review performed by Graziani L. et al. [10] 
on 417 consecutive diabetic patients has allowed the development of a more 
specific  morphological  classification  describing  the  infrapopliteal  arterial 
involvement in diabetic PAD; this classification seems to be correlated to the 
clinical  severity  of  the  disease.  Furthermore,  it  is  well-known  from  the 
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clinical experience that the angiographic presentation of peripheral diabetic 
macroangiopathy  does  not  directly  correspond  to  the  clinical  situation  of 
every  specific  patient,  and  in  the  absence  of  a  direct  dialogue  with  the 
clinicians, sometimes there could be difficulties in understanding which one is 
the  limb or  the  target  lesion  to  treat.  Furthermore,  recently,  the  so-called 
“angiosome model” has been successfully proposed,  underline the need to 
treat specifically the wound-related artery allowing direct blood flow to the 
lesion to improve the final clinical result [11,12].
The aim of this study was to retrospectively evaluate the correlation between 
the  clinical  scenario,  in  terms  of  lesion  severity  and  clinical  success  of 
treatment,  and  the  vascular  damage  evaluated  by  the  angiographic  study, 
before and after the treatment, in a homogeneous series of diabetic patients 
with ischemic foot, consecutively treated with percutaneous revascularization
from January 2009 to June 2011.
5
MATERIALS AND METHODS
We retrospectively collected the data of all the diabetic patients with chronic 
critical  limb  ischemia,  defined  by  the  presence  of  trophic  lesions  and/or 
ischemic  rest  pain,  according  to  the  definition  of  the  TransAtlantic 
InterSociety  Consensus [9],  submitted  to  infrainguinal  percutaneous 
revascularization between January 2009 and June 2011, and admitted from the 
Diabetic Foot Clinic of our University Hospital.
All  pre-procedural  data  were  collected,  with  particular  reference  to:  age, 
gender, comorbidities,  diabetes type and duration in years, serum levels of 
HbA1c  and  creatinine,  lesion  location  and  severity,  according  to  the 
classification of  the Texas University (Table 1)  [13].  All  the patients  with 
suspected  or  proven  diagnosis  of  PAD  underwent  digital  subtraction 
angiography  (DSA;  digital  subtraction  angiography;  GE Innova 4100), by 
percutaneous  transfemoral  arterial  access  controlateral  to  the  target  limb, 
under local anaesthesia, with 4Fr Pigtail catheter (Cordis Corporation; Miami, 
FL, USA), in order to map the arterial tree.
Every single  case was discussed in  a  multidisciplinary team composed by 
interventional radiologists, diabetologists, and vascular surgeons, in order to 
establish the most proper therapeutic option. This study included only patients 
indicated for endovascular revascularization. 
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Technique of endovascular revascularization 
The endovascular  revascularization  was  performed,  after  obtaining written 
informed  consent,  with  an  orthodromic  ispilater  puncture  of  the  common 
femoral  artery  (4-  to  5-Fr  introducer  sheath),  under  local  anaesthesia;  in 
selected cases, a contralateral access was chosen followed by the cross-over 
the  iliac  axis.  The  steno-obstructions  were  overcome  with  hydrophilic 
guidewires  and  multiple  angioplasties  were  performed  with  3-  to  6-mm 
balloon catheters with variable length depending on the target vessel. 
Treatment was considered successful in the presence of a direct flow in the 
treated vessels with residual stenosis <30% of the vessels’ diameter. In the 
presence of angioplasty-resistant stenosis, or dissection complicating the flow, 
a stent was deployed. In specific cases, the revascularization was performed 
by subintimal angioplasty, according to the technique described by Bolia et al 
[14,15]. To reduce the risks of thrombo-embolic phenomena, all patients were 
administered a bolus of heparin (routinely, 5000 IU) just before treatment.
Other Treatments
Following  the  procedure,  an  anticoagulation  protocol  was  required  in  all 
patients, including fractioned heparin (1 mg per day in the first week, 0.5 mg 
per day from the second to the fourth week) and ticlopidine (250 mg per day) 
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or  acetylsalicylic  acid  (300  mg  per  day)  starting  from  the  second  week. 
Medical therapy of comorbidities was carefully performed when required.
The lesions were treated, when necessary, with local surgical approach (such 
as  debridment,  minor  amputations)  in  the  days  following  the 
revascularization, with the exception of infected lesions for which a surgical 
treatment was performed in emergency the day before revascularization.
Major amputations were considered and carried out, with the patient consent, 
in  cases  where  revascularization  did  not  lead  to  a  meaningful  lesion 
improvement. 
Post-Procedural  Follow-Up
All  patients  underwent  color-coded  Duplex  Ultrasound  24  hours  after  the 
procedure. After discharge, follow-up clinical examinations were carried out 
(with different time intervals, depending on each single case) at the Diabetic 
Foot Clinic, for the adaptation of the systemic antibiotic therapy based on the 
results obtained from the microbiological exams, for the local medications 
and for the drainage until complete wound healing.
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Data Collection
The clinical and epidemiological data were collected from the clinical files. 
The  angiographic  data  were  collected  via  the  analysis  of  the  reports  and 
images  stored  on  the  computer-system  of  R.I.S.-P.A.C.S  (Radiology 
Information System-Picture  Archiving and Communication  System) of  the 
Interventional Radiology Unit.  The data concerning the surgical  operations 
and  the  follow-up  of  patients  were  collected  by  the  analysis  of  the 
computerized clinical folders, stored on the information system E-upodi@ of 
the Diabetic Foot Clinic.
Evaluation of the clinical results
The clinical result was defined, based on lesion evolution, as healing, stability 
and worsening, the latter leading to major amputation. Time for healing was 
calculated from the time of the revascularization procedure,  where healing 
was  defined  as  the  complete  and  durable  re-epithelization  of  the  lesion, 
according to the International Consensus on Diabetic Foot [16]. Ipsilateral or 
contralateral recurrence was defined as recurrence of rest pain, onset of new 
lesions or relapse of the primary lesion after recovery. 
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Evaluation of the angiographic results
The  angiographic  acquisitions  of  the  peripheral  arteries,  before  and 
immediately  after  treatment,  were  retrospectively  reviewed  by  two 
interventional radiologists in consensus, in order to classify the preprocedural 
and  post-procedural  arterial  involvement,  using  three  different  scoring 
systems:
1) TASC II classification for the femoro-popliteal lesions [9] (Table 2);
2) Classification according to Graziani L. et al [10] which provides 7 different 
classes  with  progressively  increasing  arterial  involvement  (Table  3);
3) The Joint Vascular Societies Council classification [17,18] which provides 
a score from 0 to 3 on the basis of  the most  severe stenosis  (score 0 fro 
stenosis  less  than 20%,  score  1  for  20-49% stenosis,  score  2  for  50-99% 
stenosis, score 2.5 for occlusion of less than half the total length of the vessel, 
score 3 for longer occlusion).  The following arteries were included in the 
analysis:  anterior  tibial  (AT),  posterior  tibial  (PT),  peroneal  including  the 
tibio-peroneal  trunk  (Per),  dorsalis  pedis  (DP),  lateral  plantar  (LP),  and 
medial plantar (MP). We evaluated the DP on its entire length  from the ankle 
joint level to the level at which it gives off its arcuate branch. We counted up 
a “foot score” (sum of the 3 foot vessels scores plus 1) and a “calf score” 
(sum of the 3 calf vessels scores plus 1).
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Statistical analysis
The data were evaluated via descriptive statistics (mean, median and standard 
deviation,  DS)  and  compared  with  the  chi-square  or  Fisher  test  for  the 
categorical data and the Student's t test for the continuous variables. 
Lesion  severity  and  clinical  results  were  evaluated  in  relationship  to  the 
clinical and pre- and post-procedural angiographic variables.
The statistical analysis was performed with the SAS software (SAS Institute, 
Cary, NC). A P-value of less than 0.05 was considered statistically significant.
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RESULTS
The  study  included  202  percutaneous  revascularizations  in  166  patients 
(males/females:  115/51,  mean  age:  72.8±9.8  years);  the  clinical  and 
demographic data, collected at the time of each procedure, are reported in 
Table 4.
Lesion  severity  resulted  to  be  significantly  associated  with  patients'  age 
(P=0.03),  with  higher  age  (mean  74.7  years)  in  patients  with  1C  lesions 
compared to patients with 2D lesions (mean 62.9 years) (Table 5). Moreover, 
type  D  lesions  (i.e.  with  infectious  component)  were  significantly  more 
frequent  in  patients  with  diabetic  retinopathy  (P=0.0007)  and  with  higher 
levels of  HbA1c (P=0.01). 
At the pre-procedural angiograms, the mean calf score was 7.8±1.6 (median 
8), while the mean foot score was 7.3±2.3 (median 8); in 112 angiographies 
(55.4%) the TASC II classification resulted to be inapplicable; finally, 132 
angiographies  (65.3%)  fell  within  the  Graziani’s  morphological  classes 
ranging from 4 to 7, with 7 (3.5%) cases that were not classifiable for the 
absence  of  below-the-knee  arterial  occlusions  (Table  6).  We  observed  a 
significant  correlation  between  Graziani’s  morphological  classes  and  calf 
(p<0.0001) and foot (p<0.001) scores. The pre-procedural calf and foot scores 
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were  statistically  lower  in  patients  with  2D lesions  (P=0.002 and P=0.03, 
respectively).
The  revascularization  procedure  was  technically  successful  in  189  cases 
(93.6%).  At  the  final  angiographic  examination,  the  mean  calf  score  was 
4.8±2.3 (median 4) with an mean reduction of 3±1.9 (range 0-8), while the 
mean foot score was 5.9±2.6 (median 6.5), with an mean reduction of 1.4±1.6 
(range,-2,5-8). At the end of the procedure, 175 angiographies (86.6%) were 
classified in Graziani’s morphological classes of 1 and 2, while the TASC II 
classification resulted to be inapplicable in all cases, following the successful 
revascularization of the femoro-popliteal axis in all the required patients.
Clinical  follow-up  was  available  in  181  cases.  At  latest  follow-up,  121 
(66.8%)  procedures  had  determined  complete  ulcer  healing,  with  a  mean 
healing  time  of  28.4±23.7  weeks.  In  53  cases  (29.3%),  the  lesion  was 
clinically stable, whereas in 7 cases (3.9%) major amputation was required a 
mean  of  30.7±24.6  weeks  after  the  revascularization  procedure.  Minor 
amputations were performed in 19 cases a few days before the procedure and 
in 59 cases, a mean of 6±5 days after the revascularization procedure.
Ulcer healing was significantly associated with lower pre-procedural (mean 
score 7 in healed patients and 7.8 in non-healed patients; P=0.049) and post-
procedural (mean score 5.5 in healed patients and 6.3 in non-healed patients; 
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P=0.047) foot scores. All the remaining clinical and angiographic variables 
included  in  the  analysis  did  not  result  to  significantly  affect  the  clinical 
outcome (Tables 7,8,9).
Ipsilateral recurrence rate was  37.8% (n=68) after a mean of 28±23 weeks 
from revascularization  (range  8-981  days).  For  the  contralateral  limb,  the 
incidence of lesion recurrence was 23.3% (n=42) after a mean of 24.6±25.7 
weeks  (range  5-903  days).  Ipsilateral  recurrence  was  significantly  more 
frequent in patients with type D lesions (P=0.004).
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DISCUSSION
PAD is a relatively common complication of diabetes mellitus that can be 
underestimated,  although it  is  associated with a  higher  risk of  CLI,  major 
amputation  and  death  compared  to  the  non-diabetic  population. 
Revascularization  is  therefore  required  either  by  percutaneous  or  surgical 
approach, providing evidence of clinical benefits. 
In the Eurodiale study, which involved 1300 patients of 14 specialized centers 
in 10 European countries, it has emerged how the  severity of PAD heavily 
influences  the  risk  of  major  amputation  as  well  as  the  incidence  of  co-
morbidities [19].
Our retrospective study on diabetic patients with CLI focused on the possible 
correlation between severity of arterial involvement and clinical results. 
Our  baseline  clinical  data  show how diabetic  patients  with  CLI  are  aged 
patients,  with  multiple  co-morbidities  and  microvascular  as  well  as 
macrovascular multiple diseases. Coronary artery disease was present in about 
one third of  the patients,  whereas 10% of  the population was affected by 
cerebrovascular disease, and hypertension was found in over 50% of cases. 
Among micro-vascular complications, diabetic retinopathy was registered in 
53% of patients, nephropathy in 32.2%, and neuropathy in 16.3% of patients.
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Regarding the limb lesions,  the vast  majority  (75.7%) of  our patients  had 
either type 2 or 3 lesions according to the Texas University, which means that 
the vast majority of the lesions involved the deeper levels. 
The lesion severity was in accordance to the degree of arterial involvement. In 
fact the median calf and foot scores were 8,  which means that there were at 
least two obstructed arteries for each district in the vast majority of our cases. 
These  scores  were  significantly  correlated to  the Graziani’s  morphological 
classification, which seems to nicely represent the arterial involvement in the 
diabetic population. in our series, the majority of patients were in Graziani’s 
classes >4, with percentages in the different classes which are comparable to 
the ones reported by Graziani et al.  in their wider cohort of patients [10]. 
However, Graziani’s classification does not take into consideration the foot 
level,  which,  in  accordance  to  our  results,  seems  to  be  the  only  factor 
significantly influencing the final clinical outcome. 
To date, TASC II guidelines are the only available international guidelines 
providing recommendations for the treatment of PAD. However, limitations 
of these guidelines have been pointed out, particularly regarding the lack of a 
proper  description  of  below-the-knee  arterial  involvement,  which  is  the 
prevalent  involvement  in  the  diabetic  population  [20].  Indeed,  our  data 
demonstrate  that  TASC  II  classification  is  often  inadequate  in  diabetic 
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patients with CLI to describe the arterial involvement. In fact, more than half 
of the patients included in the analysis weren’t referable to any of the TASC II 
classifications, and such percentage reaches 100% after treatment, either due 
to  lack of  femoro-popliteal  involvement  or  to  the successful  percutaneous 
treatment of femoro-popliteal stenoses or occlusions when present.
In agreement with previous published data [1-7],  The immediate  technical 
success rate  of  percutaneous treatment was 93.6%, while healing rate was 
almost 70%.
Healing time is however a major concern. Our mean healing time was about 6 
months, suggesting that the healing process requires careful follow-up and a 
remarkable effort both from the care provider and from the patient. Efforts are 
required  to  try  and  reduce  the  time  required  for  healing,  by  improving 
revascularization techniques and patency rates. By reviewing post-procedural 
angiographic results, we noticed how we are nowadays able to revascularize 
most of the infrapopliteal arterial districts, also due to the introduction of low-
profile  dedicated  materials,  with  a  remarkable  reductions  in  the  post-
procedural  calf  scores.  On  the  other  hand,  we  did  not  observe  the  same 
evident reduction in the post-procedural foot scores. At this level the presence 
of  heavy  calcifications,  long-lasting  chronic  occlusions  and  multiple  tiny 
collateral arteries might interfere with our technical chances of obtaining the 
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revascularization  of  an  entire  native  pedis  artery.  In  these  conditions, 
implementing  the  blood  flow into  the  collateral  arteries  is  often  the  only 
available  possibility.  However,  the  need  has  already  been  pointed  out  of 
moving from “below-the-knee” to “below-the-ankle” and feasibility has been 
reported in a few pioneer complex experiences, reserved to selected patients 
[21]. Indeed, our data demonstrate that the preprocedural and postprocedural 
foot  scores  represent  important  predictive  factors  for  ulcer  healing,  thus 
suggesting the need for further technical improvements in order to provide 
direct blood flow to the target area [11,12].
The clinical result was not significantly associated with any of the remaining 
angiographic scores. This result might represent a further confirmation of the 
unnecessary  achievement  of  an  “optimal”  angiographic  result,  by 
revascularizing  each  single  infrapopliteal  artery,  while  efforts  should 
concentrate on improving the direct blood flow to the wounded area [12],  as 
confirmed  by  good  healing  percentage  and  the  low  percentage  of  major 
amputations. The accomplishment of a “cosmetic result” could increase the 
incidence  of  possible  complications,  due  to  the  increasing  interventional 
manipulations and procedural time.
Our major amputation rate (about 4%) seems to be lower in comparison to 
previous published data [1-7]. This result could be biased by the retrospective 
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nature  of  our  study,  in  which  only  patients  candidates  to  percutaneous 
treatment  were  included.  However,  the  low  ampuation  rate  might  also 
represent a confirmation of the effectiveness of percutaneous treatment and of 
a multidisciplinary organization dedicated to diabetic foot care. 
Complete  ulcer  healing depends  on  many  variables,  such  as  patient  age, 
presence of co-morbidities, glycometabolic control, lesions size and duration 
[7],  as  well  as  patients’ compliance  to  treatment  and prevention.  In  other 
words, the “diabetic foot” has to be considered as a complex multifactorial 
disease.  The  therapeutic  approach  should,  therefore,  be  multidisciplinary 
through  the  organization  of  a  dedicated  multidisciplinary  team,  for  pre-
procedural evaluation, treatment and follow-up [22,23]. 
In  conclusion,  the  percutaneous  revascularization  represents  a  useful  and 
valuable  treatment  in  diabetic  patients  with CLI but  it  should be included 
inside a complex treatment algorithm to take care not only of the limb, but of 
the  patient  as  a  whole.  The  foot  score  represents  the  most  significant 
angiographic  parameter  to  evaluate  chances  for  ulcer  healing,  and, 
consequently, to state the success of the revascularization procedure.
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Table 1: Texas University score system
0 I II III
A No open lesion Superficial ulcer Ulcer deep to fascia, 
tendon or joint 
Ulcer penetrating joint 
or bone
B + Infection + Infection + Infection + Infection 
C + Ischemia + Ischemia + Ischemia + Ischemia
D +Ischemia and 
Infection
+Ischemia and 
Infection
+Ischemia and 
Infection
+Ischemia and 
Infection
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Table 2: TASC classification of femoro-popliteal lesions
Type A lesions  Single stenosis <10 cm in length
 Single occlusion <5 cm in length
Type B lesions  Multiple lesions (stenoses or occlusions), each <5 cm
 Single  stenosis  or  occlusion  <15  cm  not  involving  the  infra 
geniculate popliteal artery
 Single  or  multiple  lesions  in  the  absence  of  continuous  tibial 
vessels 
 Heavily calcified occlusion <5 cm i length
 Single popliteal stenosis
Type A lesions  Single stenosis <10 cm in length
 Single occlusion <5 cm in length
Type B lesions  Multiple lesions (stenoses or occlusions), each <5 cm
 Single  stenosis  or  occlusion  <15  cm  not  involving  the  infra 
geniculate popliteal artery
 Single  or  multiple  lesions  in  the  absence  of  continuous  tibial 
vessels 
 Heavily calcified occlusion <5 cm in length
 Single popliteal stenosis
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Table 3: Graziani’s classification of below-the-knee arterial lesions
Class Angiographic Finding
1 Isolated, one vessel tibial or peroneal artery obstruction
2a Isolated femoral/popliteal artery or two below knee arteries obstructed but with
 patency of one of the two tibial arteries
2b Isolated femoral/popliteal artery or two below knee tibial arteries obstructed but
 with patency of the peroneal artery
3 Isolated,  one  artery  occluded  and  multiple  stenosis  of  tibial/peroneal  and/or 
femoral/popliteal arteries
4 Two arteries occluded and multiple stenosis of tibial/peroneal and/or femoral/popliteal 
vessels
5 Occlusion of all tibial and peroneal arteries (below knee cross-sectional occlusion)
6 Three  arteries  occluded  and  multiple  stenosis  of  tibial/peroneal  and/or 
femoral/popliteal arteries
7 Multiple  femoro-popliteal  obstructions  with  no  visible  below  the  knee  arterial 
segments
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Table 4: Patients’ demographic and clinical data
Variable N
Age (years, mean ± SD) 71.8 ± 9.8 (range 39-89)
Gender (M/F) 142 / 60
Comorbidity
  Coronary artery disease 65 (32.2%)
  Other cardiac disease 44 (21.8%)
  Cerebrovascular disease 22 (10.9%)
  Hypertension 124 (61.4%)
  Retinopathy 107 (53%)
  Nephropathy 65 (32.2%)
  Neuropathy 33 (16.3%)
  Charcot 10 (5%)
HbA1c 
(%, mean ± SD)
7.8 ± 1.8 (range 0.9-14.5)
Creatinine (mg/dl, mean ± SD) 1.68  ± 1.9 (range 0.5-13.4)
Diabetes type
1 / 2
3 / 199
Diabetes duration (years, mean ± SD) 20.5 ± 12.1 (range 0.1-47)
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Table 5: Data regarding the foot lesion 
Characteristics N
> 1 lesion 21 (10.4%)
Lesion duration (weeks) 16 ± 24 (range 1-192)
Texas University Classes 142 / 60
  0C 4 (2%)
  1C 39 (19.3%)
  2C 10 (5%)
  3C 46 (22.7%)
  1D 6 (3%)
  2D 9 (4.4%)
  3D 88 (43.6%)
Location (n=221)
  Forefoot 174 (78.7%)
  Midfoot 6 (2.7%)
  Hindfoot 24 (10.9%)
  Leg 17 (7.7%)
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Table 6:  Preprocedural angiographic classifications
a) TASC
B C D NA
Total 63 (31.2%) 1 (0.5%) 26 (12.9%) 112 (55.4%)
b) Graziani
1 2a 2b 3 4 5 6 7 NA
Total
(%)
5
(2.5)
4
(2)
4
(2)
50
(24.7)
66
(32.6)
15
(7.4)
42
(20.8)
9
(4.5)
7
(3.5)
c) The Joint Vascular Societies  
Leg AT PT PER
Total 7.8±1.7 2.4±0.9 2.6±0.8 1.8±1.0
Foot DP LP MP
Total 7.3±2.3 2.0±1.0 2.1±1.1 2.2±1.1
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Table 7: Pre-and post-procedural morphologic evaluation according to TASC 
II classification, compared to clinical outcome
Total Healing
(n=121)
Non-healing
(n=60)
p
Pre- PTA 0.31
B 56 40 (22.1%) 16 (8.8%)
C 1 0 1 (0.5%)
D 21 12 (6.6%) 9 (5.0%)
NA 103 69 (38.1%) 34 (18.8%)
Post- PTA NA
B 0 0 0
C 0 0 0
D 0 0 0
NA 181 121 (66.8%) 60 (33.2%)
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Table 8: Pre-and post-procedural morphologic evaluation according to 
Graziani’s Classification, compared to clinical outcome
Total Healed (n=121) Not healed (n=60) p
Pre-PTA 0.89
1 4 3 (1.7%) 1 (0.6%)
2a 4 3 (1.7%) 1 (0.6%)
2b 4 3 (1.7%) 1 (0.6%)
3 47 34 (18.8%) 13 (7.2%)
4 59 36 (19.9%) 23 (12.7%)
5 14 11 (6.1%) 3 (1.7%)
6 38 24 (13.3%) 14 (7.7%)
7 4 2 (1.1) 2 (1.1%)
NA 7 5 (2.8%) 2 (1.1%)
Post-PTA 0.31
0 31 21 (11.6%) 10 (5.5%)
1 79 54 (29.8%) 25 (13.8%)
2a 27 15 (8.3%) 12 (6.6%)
2b 23 19 (10.5%) 4 (2.2%)
3 7 4 (2.2%) 3 (1.7%)
4 4 2 (1.1%) 2 (1.1%)
5 4 1 (0.6%) 3 (1.7%)
6 3 2 (1.1%) 1 (0.6%)
7  1 1 (0.6%) 0
NA 2 2 (1.1%) 0
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Table 9: Pre-and post-procedure morphologic evaluation according to the 
guidelines of The Joint Vascular Societies, compared to clinical outcome
Total Healing
(n=121)
Non-healing
(n=60)
p
Pre- PTA
Anterior tibial 2.4± 0.9 2.4± 0.9 2.3± 0.8 0.85
Posterior tibial 2.6± 0.7 2.5± 0.8 2.7± 0.6 0.22
Peroneal 1.8± 1.0 1.7± 1.1 2.0± 0.9 0.03
Leg 7.7± 1.7 7.5± 1.8 8.0± 1.5 0.07
Dorsalis 2.0± 0.9 1.9± 1.0 2.2± 0.9 0.09
Lateral plantar 2.1± 1.1 2.0± 1.1 2.3± 0.9 0.08
Medial plantar 2.2± 1.1 2.1± 1.1 2.3± 1.0 0.32
Foot 7.3± 2.4 7.0± 2.5 7.8± 2.0 0.049
Post- PTA NA
Anterior tibial 1.7± 1.4 1.2± 1.4 1.0± 1.4 0.42
Posterior tibial 1.7± 1.5 1.7± 1.5 1.8± 1.4 0.50
Peroneal 0.7± 1.2 0.60± 1.1 1.0± 1.2 0.07
Leg 4.6± 2.3 4.5± 2.2 4.8± 2.4 0.38
Dorsalis 1.3± 1.2 1.3± 1.2 1.4± 1.2 0.53
Lateral plantar 1.7± 1.3 1.5± 1.3 2.0± 1.2 0.02
Medial plantar 1.7± 2.3 1.7± 1.3 1.9± 1.3 0.27
Foot 5.8± 2.6 5.5± 2.7 6.3± 2.3 0.047
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